CORC

在结果中检索

CORC

浏览/检索结果: 共16条，第1-10条 帮助

限定条件                    
已选(0)清除 条数/页：   排序方式：
Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent (R) System) compared to TIVOLI in the Treatment of Patients with Coron 会议论文
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018-10-16
作者:  Han, Yaling;  Wang, Zhiyong;  Pei, Hanjun;  Zhang, Li;  Yang, Yuejin
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
A randomized, double-blind, placebo-controlled, multi-centered phase 3 trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer (FRESCO). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Li, Jin;  Qin, Shukui;  Bai, Yuxian;  Deng, Yanhong;  Yang, Lei
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04
A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating m 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04
Survival outcomes of the NeoALTTO study: Updated results of a randomized multicenter phase III neoadjuvant trial 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Huober, Jens Bodo;  Holmes, Eileen McCormick;  Baselga, Jose;  De Azambuja, Evandro;  Untch, Michael
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/04
Anlotinib versus sunitinib as first line treatment for metastatic renal cell carcinoma (mRCC): Preliminary results from a randomized phase II clinical trial 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Zhou, Ai-Ping;  Ma, Jianhui;  Bai, Yuxian;  Song, Yan;  Li, Hangzhong
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/04
Randomized phase III trial of utidelone, a genetically engineered epothilone analog, in combination with capecitabine versus capecitabine alone for metastatic breast cancer patients with previous taxane and anthracycline treatment. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Xu, Binghe;  Sun, Tao;  Zhang, Qingyuan;  Yuan, Zhongyu;  Zhang, Pin
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04
STORM: A phase III randomized, double-blind, placebo-controlled trial of adjuvant sorafenib after resection or ablation to prevent recurrence of hepatocellular carcinoma (HCC) 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20
作者:  Bruix, Jordi;  Takayama, Tadatoshi;  Mazzaferro, Vincenzo
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/13
Survival with docetaxel plus capecitabine comparing with vinorelbine plus capecitabine followed by capecitabine maintenance treatment as first-line therapy in patients with advanced breast cancer: A phase III randomized clinical trial 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2014-05-20
作者:  Xu, Binghe;  Wang, Jiayu;  Li, Qing;  Zhang, Pin;  Yuan, Peng
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13
Cetuximab plus mFOLFOX-6 as first-line therapy for unresectable liver metastases from colorectal cancer: an open-label, non-randomized, multicenter phase II clinical trial (CLIME Study) 会议论文
EUROPEAN JOURNAL OF CANCER, 2013-09-01
作者:  Cai, S.;  Zhang, W. E. N.;  Li, W.;  Xu, Y.;  Gu, W.
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13
Phase III, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and vinorelbine in trastuzumab-resistant, advanced breast cancer (BOLERO-3). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2013-05-20
作者:  O'Regan, Ruth;  Ozguroglu, Mustafa;  Andre, Fabrice;  Toi, Masakazu;  Jerusalem, Guy Heinrich Maria
收藏  |  浏览/下载：2/0  |  提交时间：2020/01/13

©版权所有 ©2017 CSpace - Powered by CSpace